Innovative Targeted and Immune-Mediated Cancer Therapies
Pipeline
Developing first-in-class oral drug therapeutics with broad potential benefit for cancer patients
Science
Thoughtful exploration of new and validated pathways to discover and develop novel therapeutics
News
December 6,
2024
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 25,
2024
Tempest to Participate in the Piper Sandler 36th Annual Healthcare Conference
November 12,
2024
Tempest Reports Third Quarter 2024 Financial Results and Provides Business Update
Events
Tuesday,
December 3RD,
2024
at
9:00 AM
Eastern
Piper Sandler 36th Annual Healthcare Conference
Listen: Webcast
Thursday,
June 20TH,
2024
at
8:30 AM
Eastern
Amezalpat (TPST-1120) Global Randomized Phase 1b/2 Combination Study Update Call
Listen: Webcast
Download: Presentation [pdf]
Wednesday,
October 11TH,
2023
at
8:30 AM
Eastern
TPST-1120 Global Randomized Phase 1b/2 Combination Study Data Call
Listen: Webcast
Download: Presentation [pdf]